AlzChem Group Valuation
| ACT Stock | 57.20 0.40 0.70% |
At this time, the firm appears to be overvalued. AlzChem Group AG shows a prevailing Real Value of USD51.11 per share. The current price of the firm is USD57.2. Our model approximates the value of AlzChem Group AG from analyzing the firm fundamentals such as Profit Margin of 0.05 %, return on equity of 0.27, and Current Valuation of 272.35 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AlzChem Group's price fluctuation is very steady at this time. Calculation of the real value of AlzChem Group AG is based on 3 months time horizon. Increasing AlzChem Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
AlzChem Group's intrinsic value may or may not be the same as its current market price of 57.20, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 57.2 | Real 51.11 | Hype 57.2 | Naive 55.69 |
The intrinsic value of AlzChem Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AlzChem Group's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of AlzChem Group AG helps investors to forecast how AlzChem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AlzChem Group more accurately as focusing exclusively on AlzChem Group's fundamentals will not take into account other important factors: AlzChem Group Total Value Analysis
AlzChem Group AG is presently anticipated to have takeover price of 272.35 M with market capitalization of 189.03 M, debt of 43.35 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AlzChem Group fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
272.35 M | 189.03 M | 43.35 M |
AlzChem Group Investor Information
About 53.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. AlzChem Group AG last dividend was issued on the 6th of May 2022. The entity had 1:10 split on the 1st of July 2019. Based on the analysis of AlzChem Group's profitability, liquidity, and operating efficiency, AlzChem Group AG is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.AlzChem Group Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AlzChem Group has an asset utilization ratio of 111.82 percent. This implies that the Company is making USD1.12 for each dollar of assets. An increasing asset utilization means that AlzChem Group AG is more efficient with each dollar of assets it utilizes for everyday operations.AlzChem Group Ownership Allocation
The market capitalization of AlzChem Group AG is USD189.03 Million. AlzChem Group AG retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.AlzChem Group Profitability Analysis
The company reported the revenue of 422.29 M. Net Income was 27.59 M with profit before overhead, payroll, taxes, and interest of 258.3 M.About AlzChem Group Valuation
The stock valuation mechanism determines AlzChem Group's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of AlzChem Group AG based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of AlzChem Group. We calculate exposure to AlzChem Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AlzChem Group's related companies.8 Steps to conduct AlzChem Group's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AlzChem Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AlzChem Group's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AlzChem Group's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AlzChem Group's revenue streams: Identify AlzChem Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AlzChem Group's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AlzChem Group's growth potential: Evaluate AlzChem Group's management, business model, and growth potential.
- Determine AlzChem Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AlzChem Group's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for AlzChem Stock Analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.